Neurocrine Biosciences | NBIX - Eps Zysk Na Akcję

Cena Akcji
131.25
Dzienna Zmiana
3.13 2.44%
Miesięcznie
1.97%
Rocznie
21.88%
Q2 Prognozy TE
124.95

Fiscal Kalendarz Obecny Prognoza Poprzedni Data
FY2026Q1 Mar/2026 1.15 0.70 May/05
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28
FY2025Q2 Jun/2025 1.65 0.98 1.63 Jul/30
FY2025Q1 Mar/2025 0.70 0.86 1.20 May/05




Eps Zmiana Data
AbbVie USD 2.65 0.06 2026-03
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.69 0.17 2026-03
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Cytokinetics USD -1.5 1.05 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Exelixis USD 0.97 0.19 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Incyte USD 1.81 0.01 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Pfizer USD 0.66 0.21 2025-12
Prothena USD -0.46 0.22 2025-12
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Repligen USD 0.49 0.03 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sarepta Therapeutics USD -3.58 3.45 2025-12
Teva Pharmaceutical Industries USD 1.57 1.41 2026-03
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xoma USD -1.59 2.43 2024-09